– Data provide insights that informed the Phase 1 study of STK-002 as a potential disease-modifying medicine for ADOA, including disease etiology, progression and clinical assessments – – ADOA is a ...

Prima, developed by US medtech company Science Corporation, comprises a tiny chip, measuring about 2mm by 2mm and the same thickness as a human hair, as well as augmented reality glasses and a pocket ...

Optic atrophy is a degenerative disease of the optic nerve that leads to gradual damage to the retinal ganglion cells —the nerve cells that transmit visual signals from the retina to the brain. The ...

Optic atrophy is a degenerative disease of the optic nerve that leads to gradual damage to the retinal ganglion cells - the nerve cells that transmit visual signals from the retina to the brain. The ...

A deep-learning model trained on optical coherence tomography scans of the optic nerve head reliably distinguished among various types of optic nerve damage, such as glaucoma, non-arteritic anterior ...

New research links two widely used diabetes drugs, semaglutide or tirzepatide, to a rare but potentially vision-threatening eye condition, raising questions about drug-specific risks and the need for ...

A 38-year-old woman with trisomy 21 presented with unilateral optic nerve atrophy due to Moyamoya Disease (MMD). She had a narrow palate, epicanthal folds and moderate developmental delay. Her past ...

Morning Glory Syndrome (MGS) is a rare and complex disease that necessitates a multidisciplinary approach for effective management and enhanced patient outcomes, according to Suping Wu, MD, and ...

Background/aims The analysis of visual field loss patterns is clinically useful to guide differential diagnosis of visual pathway pathology. This study investigates whether a novel index of macular ...